Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07131592 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Intravenous and Topical Tranexamic Acid on Drain Output in Breast Reduction Surgery

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Nov 1, 2025 to Nov 18, 2025v3 Show 1 more changeShow less
    • Start date changed from estimate of Nov 1, 2025 to Nov 18, 2025
  2. Start date: Sep 1, 2025 to Nov 1, 2025v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate whether tranexamic acid (TXA), a medication that helps reduce bleeding, can decrease fluid drainage after breast reduction surgery. Participants will be randomly assigned to receive either intravenous TXA or no TXA during surgery. Additionally, one breast will receive TXA through the surgical drain, while the other will receive saline. This approach allows to compare the effects of TXA on fluid buildup and healing. The goal is to improve recovery and reduce complications after breast reduction surgery.
Trial Details
NCT Number NCT07131592
Lead Sponsor Massachusetts General Hospital
Conditions Drain Output After Breast Reduction Surgery, Breast Reductions
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov